AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2022
Jun 9, 2022
32559_dirs_2022-06-08_d0815153-0887-441c-836b-c3c9aa655539.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2022-05-31
Reporting Person: Yoon Seokho Bryan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-31 | Common Stock | P | 7656.00 | $1.47 | Acquired | 7656.00 | Direct |
Footnotes
F1: Includes the purchase of 7,656 shares under the Terns Employee Stock Purchase Plan on May 31, 2022.